EGFR is highly conserved in pancreatic cancer tissues and EGFR inhibition has been shown to be an effective therapeutic strategy against pancreatic cancer [39], since the EGF/EGFR pathway activates downstream pro-oncogenic signaling pathways, resulting in proliferation and metastasis of cancer cells [40]. The gene discussed is EGFR; the disease is cancer.